At the scientific session of the American Heart Association held in Chicago, cardiologists from Germany presented the results of an extended follow up of 2,603 patients who were randomised to treatment with two new generation stents — everolimus eluting Xience and sirolimus eluting Yukon Choice — and a first generation sirolimus eluting Cypher stent.
from Times of India https://ift.tt/2zRFOZb
Thursday, November 15, 2018
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment